its unstable hydrochloride and its nitroso derivative. For nearly 50 years thereafter iminodibenzyl attracted no further attention and was not investigated in any way.
In 1948 we became interested in the compound and included it as a starting material in a broader project involving the synthesis of basically substituted heterocyclic compounds. This project was a continuation of earlier work on antihistaminics, its goal being the synthesis of compounds of potential value as sedatives, analgesics, drugs for treatment of Parkinson's disease, etc. We synthesized a series of derivatives of iminodibenzyl (3), among others those whose structures are shown in Figure 2 . In the pharmacologic screening, these compounds showed generally antihistaminic and anticholinergic activity, and some of them in addition showed distinct sedative and analgesic properties (4). 
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A few selected compounds were then tested in normal human volunteers, and confirmation of the sedative or hypnotic properties, varying in degree between the several compounds, was thereby obtained (5) . Based on these results one compound, G 22150, was selected for clinical investigation (Figure 3 ). The clinical results confirmed the first impressions: G 22150 showed definite hypnotic activity which was, however, not as reliable as that of the barbiturates. The iminodibenzyl derivatives gained for us in importance and interest when it was shown by Delay and Deniker (6) that a phenothiazine derivative, chlorpromazine, was of therapeutic value in the treatment of psychiatric disorders. Like chlorpromazine, some of our iminodibenzyl derivatives had proved to be active in the potentiation of narcosis and "artificial hibernation." Indeed the first iminodibenzyl derivative which was clinically investigated in psychiatry, G 22150, manifested a therapeutic effect comparable to that of chlorpromazine although in a somewhat less potent and less predictable manner. In further tests another compound of the series, G 22355, was found to be of special therapeutic value in the treatment of depressive states (7) , a condition in which neither chlorpromazine nor promazine is of value although the latter compound is the exact analog of G 22355 in the phenothiazine series. Chemically designated 5-(3-dimethylaminopropyl)-lO, II-dihydro-5H-dibenz[b,f]azepine hydrochloride, G 22355 was introduced in Europe early in 1958 as Tofranil t after extended clinical trials.
G 22150
The remarkable differences in the therapeutic effect and certain pharmacologic properties on the one hand, and the structural resemblances between Tofranil, chlorpromazine, and more especially promazine, on the other, invite one to speculate on the relationship between structure and activity (see Figures 4 and 5) . At the present stage of our knowledge such speculation may be considered presumptuous. No harm can be done, however, by some closer scrutiny and consideration of the structures of promazine and Tofranil, Within the limitations inherent in all molecular models, it is obvious that the molecules of both promazine and Tofranil have nearly the same spatial volume and shape and that the side chains and the distance between the two nitrogen atoms are identical. At first glance the only difference between the two structures seems to be the bridge between the two benzene rings, in promazine a sulfur atom, in Tofranil a -CH2-CH2-group. From the chemical point of view this means that in the tTrade Mark. phenothiazine ring system the S-atom enables the conjugation of the benzene rings to extend over the bridge, whereas the -CH2-CH2-group in Tofranil acts as a barrier to conjugation. That this is actually the case is clearly suggested by the U. V. spectra of promazine and Tofranil, as shown in Figure 6 . Whereas Tofranil shows only one maximum at 250.5 mu, promazine shows two. maxima at 251.5 mu and 301 mu as a result of the extended system of conjugation previously mentioned.
Another difference between the two molecules becomes apparent if we focus our attention on the relative positions of the two benzene rings in the respective models (Figure 7) . In contrast to promazine, which is a symmetrical molecule, the molecule of T ofranil is asymmetrical, the two benzene rings being twisted against each other. It is clear that these structural differences between the two molecules must be responsible for the differences in their biologic action. Nothing is known, however, about the mechanisms linking the structures of these compounds with their biologic activity.
A comparison of a few physicochemical properties of promazine and Tofranil shows no great differences (Table 1) . Interesting to note are the very similar pK values, indicating a similar strength of the two bases. The R, values, in the acid system used, show a slight but distinct difference, whereas they are identical in the neutral system. Our biochemical studies on resorption, distribution and disposition of Tofranil have up to now not progressed as far as we would like. We have been limited by the lack of a sufficiently sensitive method of assay. Our efforts in this respect are, how- VolA, 1959 The distribution of Tofranil in the rabbit is rather interesting / (Figure 8 ). Especially noteworthy are the relatively high levels in the brain as compared with those in the body fat, and those of heart muscle against ordinary muscle. We hope that in the near future more sensitive analytical methods (spectrofluorornerric or tracer methods) may help us towards better knowledge of the biochemistry of Tofranil and thus provide us perhaps with a better understanding of its mode of action.
Resmne
Le Tofranil, chlorhydrate de 5-(3-dimethylaminopropyl)-lO,1l-dihydro-5Hdibenzjb.fjazepine, a preuve sa valeur therapeutique dans le traitement des etats depressifs. L'auteur discute les structures chimiques de la promazine et du Tofranil, et met en evidence leurs differences.
Certaines proprietes physicochimiques de ces deux corps sont comparees, L'auteur expose en outre les resultats de l'etude biochimique du Tofranil, en particulier la maniere dont il se repartit dans les differents tissus chez le lapin.
